Vimarsana
Biggest News Aggregation in the World

Page 22 - Genentech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genentech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genentech Today - Breaking & Trending Today

Navigating Biosimilar Lifecycles: Key Considerations for Sustainable Cost Savings - Vimarsana News

Navigating Biosimilar Lifecycles: Key Considerations for Sustainable Cost Savings

With 50 biosimilar products approved by the FDA, questions arise regarding biosimilar lifecycles and sustainability of the industry.

Biologics for Severe Asthma Present Opportunities for Pharmacists - Vimarsana News

Biologics for Severe Asthma Present Opportunities for Pharmacists

Drug therapy workups may reveal candidates for immune therapy and provide chance for interventions.

Ascendis Pharma A/S : Form 6-K - MarketScreener - Vimarsana News

Ascendis Pharma A/S : Form 6-K - MarketScreener

6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K ...

Can At-Home Vision Tests Detect Active Neovascular AMD? - Vimarsana News

Can At-Home Vision Tests Detect Active Neovascular AMD?

Report suggests several tools are inadequate, but app developers question the findings

Much-Improved Outcomes for Follicular Lymphoma Transformed to DLBCL in the Rituximab Era, Study Finds - Vimarsana News

Much-Improved Outcomes for Follicular Lymphoma Transformed to DLBCL in the Rituximab Era, Study Finds

Although histological transformation to diffuse large B-cell lymphoma (DLBCL) remains a common complication of follicular lymphoma, patient survival has increased significantly since the introduction of rituximab about 2 decades ago.

Source: ajmc.com